Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sleep disturbance in schizophrenia.

Jaime M Monti1, Daniel Monti

  • 1Department of Pharmacology and Therapeutics, Clinics Hospital, Montevideo, Uruguay.

International Review of Psychiatry (Abingdon, England)
|October 1, 2005
PubMed
Summary

Insomnia is common in schizophrenia, affecting sleep onset and maintenance. Sleep architecture changes, like reduced stage 4 sleep and rapid eye movement (REM) latency, are observed in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning-based multimodality classification of chronic mild traumatic brain injury using resting-state functional MRI and PET imaging.

Frontiers in neuroscience·2024
Same author

Treatment effects of N-acetyl cysteine on resting-state functional MRI and cognitive performance in patients with chronic mild traumatic brain injury: a longitudinal study.

Frontiers in neurology·2024
Same author

Identification of chronic mild traumatic brain injury using resting state functional MRI and machine learning techniques.

Frontiers in neuroscience·2023
Same author

Correction: Coppock et al. Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. <i>Life</i> 2022, <i>12</i>, 453.

Life (Basel, Switzerland)·2022
Same author

Continuous glucose monitoring metrics for earlier identification of pre-diabetes: protocol for a systematic review and meta-analysis.

BMJ open·2022
Same author

Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial.

Life (Basel, Switzerland)·2022

Area of Science:

  • Neuroscience
  • Psychiatry
  • Sleep Medicine

Background:

  • Insomnia is a frequent symptom in schizophrenia, impacting sleep onset and maintenance.
  • Sleep disturbances are present in schizophrenic patients irrespective of medication or clinical phase.
  • Observed sleep architecture alterations include reduced stage 4 sleep and shortened rapid eye movement (REM) latency.

Purpose of the Study:

  • To summarize the characteristics of insomnia in schizophrenia.
  • To review alterations in sleep architecture associated with schizophrenia.
  • To explore potential neurotransmitter system involvement in sleep disturbances.

Main Methods:

  • Literature review of studies on insomnia and sleep architecture in schizophrenia.
  • Analysis of findings regarding sleep-onset and maintenance insomnia.
  • Examination of research on sleep stage alterations, including REM latency.

Main Results:

  • Sleep-onset and maintenance insomnia are characteristic features in schizophrenia.
  • Reduced stage 4 sleep and REM latency are common findings.
  • REM sleep duration generally remains unchanged.

Conclusions:

  • Insomnia and altered sleep architecture are integral to schizophrenia.
  • Dopaminergic system over-activity is a potential contributor to sleep disturbances.
  • The role of the GABAergic system and other neurotransmitters in REM latency reduction requires further investigation.

Related Experiment Videos